Effectiveness of three models for comprehensive cardiovascular disease risk reduction


      Cost and accessibility contribute to low participation rates in phase 2 cardiac rehabilitation programs in the United States. In this study, we compared the clinical effectiveness of 2 less costly and potentially more accessible approaches to cardiovascular risk reduction with that of a contemporary phase 2 cardiac rehabilitation program. Low- or moderate-risk patients (n = 155) with coronary artery disease (CAD) were randomly assigned to 12 weeks of participation in a contemporary phase 2 cardiac rehabilitation program (n = 52), a physician supervised, nurse–case-managed cardiovascular risk reduction program (n = 54), or a community-based cardiovascular risk reduction program administered by exercise physiologists guided by a computerized participant management system based on national clinical guidelines (n = 49). In all, 142 patients (91.6%) completed testing at baseline and after 12 weeks of intervention. For patients with abnormal (i.e., not at the goal level) baseline values, statistically significant (p ≤0.05) improvements were observed with all 3 interventions for multiple CAD risk factors. No statistically significant risk factor differences were observed among the 3 programs. For patients with a baseline maximal oxygen uptake <7 metabolic equivalents, cardiorespiratory fitness increased to a greater degree in patients in the cardiac rehabilitation program and the community-based program versus the physician-supervised, nurse– case-managed program. These data have important implications for cost containment and increasing accessibility to clinically effective comprehensive cardiovascular risk reduction services in low- or moderate-risk patients with CAD.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cooper R.
        • Cutler J.
        • Desvigne-Nickens P.
        • Fortmann S.P.
        • Friedman L.
        • Havlik R.
        • Hogelin G.
        • Marler J.
        • McGovern P.
        • Morosco G.
        • et al.
        Trends and disparities in coronary disease, stroke, and other cardiovascular diseases in the United States. Findings of the National Conference on Cardiovascular Disease Prevention.
        Circulation. 2000; 102: 3137-3147
        • Gordon N.F.
        • Haskell W.L.
        Comprehensive cardiovascular risk reduction in a cardiac rehabilitation setting.
        Am J Cardiol. 1997; 80: 69H-73H
        • Pearson T.A.
        • Peters T.D.
        The treatment gap in coronary artery disease and heart failure; community standards and the post-discharge patient.
        Am J Cardiol. 1997; 80: 45H-52H
        • Agency for Health Care Policy and Research and National Heart, Lung, and Blood Institute
        Clinical Practice Guideline Number 17, US Department of Health and Human Services; October 1995. AHCPR publication no. 96–0672 Cardiac Rehabilitation, Rockville, Md1995
      1. American Association of Cardiovascular and Pulmonary Rehabilitation. Human Kinetics Publishers, Champaign, IL1998 (Guidelines for Cardiac Rehabilitation, and Secondary Prevention Programs.)
        • Smith S.C.
        • Blair S.N.
        • Criqui M.H.
        • Fletcher G.F.
        • Fuster V.
        • Gersh B.J.
        • Gotto A.M.
        • Gould K.L.
        • Greenland P.
        • Grundy S.M.
        • et al.
        AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease.
        Circulation. 1995; 92: 2-4
        • Balady G.J.
        • Ades P.A.
        • Comoss P.
        • Limacher M.
        • Pina I.L.
        • Southard D.
        • Williams M.A.
        • Bazzarre T.
        Core components of cardiac rehabilitation/secondary prevention programs. A statement for healthcare professionals from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
        Circulation. 2000; 102: 1069-1073
        • American College of Sports Medicine
        ACSM’s Guidelines for Exercise Testing, and Prescription. 6th ed. Lippincott Williams & Wilkins, Baltimore, MD2000
        • Gordon N.F.
        Comprehensive cardiovascular disease risk reduction in the clinical setting.
        Coron Artery Disease. 1998; 9: 731-735
        • Gordon N.F.
        • Salmon R.D.
        • Mitchell B.S.
        • Faircloth G.C.
        • Levinrad L.I.
        • Salmon S.
        • Saxon W.E.
        • Reid K.S.
        Innovative approaches to comprehensive cardiovascular disease risk reduction in clinical and community-based settings.
        Curr Atherosclosis Reports. 2001; 3: 498-506
        • Bruce R.A.
        • Kusumi F.
        • Hosmer D.
        Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease.
        Am Heart J. 1973; 85: 546-562
        • Haskell W.L.
        • Alderman E.L.
        • Fair J.M.
        • Maron D.J.
        • Mackey S.F.
        • Superko R.
        • Williams P.T.
        • Johnstone I.M.
        • Champagne M.A.
        • Krauss R.M.
        • Farquhar J.W.
        Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).
        Circulation. 1994; 89: 975-990
        • DeBusk R.F.
        • Miller N.H.
        • Superko H.R.
        • Dennis C.A.
        • Thomas R.J.
        • Lew H.T.
        • Berger III, W.E.
        • Heller R.S.
        • Rompf J.
        • Gee D.
        • et al.
        A case-management system for coronary risk factor modification after acute myocardial infarction.
        Arch Intern Med. 1994; 120: 721-729
        • Buskirk E.
        • Taylor H.L.
        Maximal oxygen intake and its relation to body composition, with special reference to chronic physical activity.
        J Appl Physiol. 1957; 2: 72-78
        • Blair S.N.
        • Kohl III, H.W.
        • Paffenbarger Jr, R.S.
        • Clark D.G.
        • Cooper K.H.
        • Gibbons L.W.
        Physical fitness and all-cause mortality.
        JAMA. 1989; 262: 2395-2401
        • Vanhees L.
        • Fagard R.
        • Thijs L.
        • Staessen J.
        • Amery A.
        Prognostic significance of peak exercise capacity in patients with coronary artery disease.
        J Am Coll Cardiol. 1994; 23: 358-363
        • Blair S.N.
        • Kohl III, H.W.
        • Barlow C.E.
        • Paffenbarger Jr, R.S.
        • Gibbons L.W.
        • Macera C.A.
        Changes in physical fitness and all-cause mortality.
        JAMA. 1995; 273: 1093-1098